Briefly, FEA is a columnar cell lesion composed of low-grade atypical cells and is viewed as a precursor lesion of ADH or low-grade DCIS, but the risk of FEA alone (without ADH/ALH) for invasive breast cancer is low. This evidence concerns the gene AVP and invasive breast carcinoma.